Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 3, 2011BloodOpen Access

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD–induced myeloproliferation

View Full Paper
Ask AI
Bookmark
Share

Authors

SKShabnam KharaziLund UniversityAMAdam J. MeadNational Institute for Health ResearchAMAnna MansourCentre National de la Recherche Scientifique

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kharazi et al. (2011) studied this question.

synapsesocial.com/papers/6a0879c1ab15ea61dee8df8ehttps://doi.org/10.1182/blood-2010-06-289207
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Gain of Function Mutation in the Activation Loop of Plateletderived Growth Factor β-Receptor Deregulates Its Kinase Activity2004 · 26 citations
  2. 2Loss of Heterozygosity at theRETProtooncogene Locus in a Case of Multiple Endocrine Neoplasia Type 2A12001 · 17 citations
  3. 3Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors1995 · 595 citations
  4. 4Knock-in of an internal tandem duplication mutation into murine FLT3 confers myeloproliferative disease in a mouse model2008 · 130 citations